Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

How is night vision maintained during retinal disease?

NEI-funded research suggests that second-order neurons in the retina play a role in preserving night vision
September 24, 2020
Regenerative Medicine Retina Retinitis Pigmentosa
Basic Research
Grantee
City scene at night. Credit: Luca Bravo on Unsplash

Night vision among people with the retinal degenerative disease, retinitis pigmentosa, is maintained for a relatively long time. A new study suggests that second-order neurons in the retina may play a role in maintaining night vision. Credit: Luca Bravo on Unsplash

New research supported by the National Eye Institute may help explain how people with retinal degenerative disease can maintain their night vision for a relatively long period of time.

Researchers at the John A. Moran Eye Center at the University of Utah found that that second-order neurons in the retina, which relay visual signals to the retinal ganglion cells that project into the brain, play a key role. These neurons are able to maintain their activity in response to the degeneration of rod photoreceptors, or the cells responsible for allowing us to see at night. It’s a process known as homeostatic plasticity.

Studying a model of retinitis pigmentosa, the researchers determined that degeneration of rod photoreceptors triggered genomic and molecular changes in the retina and increased electrical signaling between rod photoreceptors and rod bipolar cells. These changes were associated with well-maintained behavioral night vision despite extensive photoreceptor cell loss. The findings were published in the journal eLife.